Next Article in Journal
Hydration Status, Fluid Intake, Sweat Rate, and Sweat Sodium Concentration in Recreational Tropical Native Runners
Previous Article in Journal
Assessment of Factors Related to Diminished Appetite in Hemodialysis Patients with a New Adapted and Validated Questionnaire
Previous Article in Special Issue
Etiology and Management of Pediatric Intestinal Failure: Focus on the Non-Digestive Causes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Diet, Nutrition and Chronic Degenerative Diseases

1
Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
2
School of Specialization in Food Science, University of Rome Tor Vergata, 00133 Rome, Italy
*
Author to whom correspondence should be addressed.
Submission received: 9 April 2021 / Accepted: 13 April 2021 / Published: 20 April 2021
(This article belongs to the Special Issue Diet, Nutrition and Chronic Degenerative Diseases)
Chronic degenerative diseases (CDDs), represented mainly by obesity, cardiovascular disease (CVD), diabetes, chronic kidney disease (CKD), inflammatory bowel diseases, osteoporosis, sarcopenia, neurodegenerative diseases such as Huntington’s disease (HD), rheumatoid arthritis (RA), chronic respiratory diseases, and many cancers, have been, up to now, the most frequent causes of prolonged disability and death worldwide [1]. About 17 million people die prematurely each year from a CDD and the number is expected to grow. Worldwide, patients with one or more CDDs represent over 30% of the population, and 70–80% of public health resources are spent today on the management of CDDs [1]; the data become even more worrying considering the most recent epidemiological projections, according to which in 2030 they will represent 80% of all diseases in the world [2].
According to the Global Burden of Disease, the major determinants of CDDs, in terms of Disability Adjusted Life Y (DALY, which is equal to the sum of years of life lost due to premature death and those experienced in disease rather than health), are mainly attributable to behavioral risk factors such as poor nutrition, reduced fruit and vegetable intake, high body mass index (BMI) (≥25.0 Kg/m2), cigarette smoking habit, high alcohol consumption, and low level of physical activity [3]. The main dietary contributing factors to deaths were: (a) reduced consumption of fruit (4.9 million attributable deaths/year), of vegetables (1.8 million), of nuts and seeds (2.5 million), of whole grains (1.7 million); (b) high sodium consumption (3.1 million).
Based on this background, the volume entitled “Diet, Nutrition and Chronic Degenerative Diseases” collects contributions focused on understanding the role of healthy, personalized nutrition, bioactive molecules and microbiota in the prevention and management of CDDs.
A range of original articles in this Special Issue (SI) highlighted the positive effect of the Mediterranean diet (MD), characterized by the extensive use of olive oil, cereals, fruit, vegetables, nuts, legumes, fish, many condiments and spices, the moderate consumption of red wine, and a low amount of dairy and meat, to prevent and manage obesity, CVD, CKD, RA and other CDDs.
Noce et al. highlighted the role of the MD in the treatment of CKD and its comorbidities, putting an effort on the antioxidant and anti-inflammatory effects of extra virgin olive oil (EVOO) [4]. Moreover, Domingues et al. proposed a supplementation protocol with creatine (Cr) to improve functional capacity and muscle oxygen saturation (StO2) in patients with symptomatic peripheral artery disease (PAD) [5]. A randomized controlled study conducted by Jalal et al. [6] proposed the consumption of Phaseolus Vulgaris (PV) to increase the urinary volume and enhance the elimination of small kidney stones.
Quattrini et al. considered the role of MD adherence level and dietary calcium intake for maintaining good bone health and preventing osteoporosis [7].
Di Renzo et al. demonstrated the role of a modified MD (mMeD), a low carbohydrate diet enriched with antioxidant compounds, as a strategy for lipoedema treatment, able to reduce the subcutaneous limbic adipose tissue that characterizes this disease and improve quality of life, such as by decreasing pain, anxiety and discomfort [8].
Lombardo et al. [9] showed the efficacy of MD, associated with aerobic physical activity, to promote weight loss in postmenopausal women and to reduce the cardiovascular and metabolic risk factors. Moreover, in obese subjects, MD adherence, assessed by PREDIMED (Prevención con Dieta Mediterránea) score, improves sleep quality and shifts the evening chronotype, associated with shorter sleep duration, later sleep timing, and caloric consumption after 8:00 p.m., towards the morning chronotype, associated with consuming more healthy foods, such as vegetables, fruits and fish, as proved by Moscogiuri et al. [10,11].
An interesting review by Merra et al. [12] summarizes the important role of polyphenols, polyunsaturated fatty acids (PUFA) ω-3 and fiber in high quantity in the typical food of the MD to control eubiosis. Moreover, since gut dysbiosis has been involved in the onset of autoimmune diseases such as RA, MD is recommended for RA patients to reduce the inflammatory mediators and a percentage of favored phyla, such as Bacteroidetes and the Firmicutes/Bacteroidetes ratio [12].
To reduce the CVD risk, Macarro et al. proposed the consumption of active products of immature citrus fruits, grapefruit (Citrus paradisi Macfad), bitter orange (Citrus aurantium L.) and olive leaf (Olea europaea L.), capable of improving flow-mediated vasodilation (FMD), blood pressure (BP), lipid profile, thrombotic status, oxidative stress, inflammation, anthropometric variables and quality of life [13]. In addition, a low dietary acid load (DAL) due to a low intake of acidogenic foods (including meat, fish, cheese, rice and cereals) and a high intake of alkaline foods (fruits, vegetables, legumes, potatoes and red wine) contributed to a reduction in cardiometabolic disorders [14]. Therefore, the Western dietary pattern could be associated with the prevalence of cardiometabolic risk factors.
An interesting cross-sectional study on Parkinson’s disease (PD) showed how changes in energy intake could be an important contributing factor to the reduction in involuntary weight loss and disease progression [15].
HD, a rare neurodegenerative disease, has been associated with low MD adherence. Therefore, increasing Mediterranean food intake and supplementing with specific nutrients, such as triheptanoin, L-acetyl-carnitine and creatine, could be the way to improve the course of HD [16].
On the basis of the papers published in the SI, it emerges that the nutritional transition of recent decades, characterized by the transition from the consumption of foods based on cereals, fruit and vegetables to foods rich in saturated fats (mainly meat and dairy products) and simple sugars, associated with a diet characterized by a higher energy intake, represents the main risk factor in the onset of CDDs.
As suggested in the SI, a solution to arrest the increase in CDDs, at least in part, could be guaranteed by preventive interventions in lifestyles and eating behaviors. The Mediterranean diet and healthy and sustainable dietary pattern promotion are aimed at reducing the modifiable exogenous risk factors, associated with the risk of obesity, CVD, CKD, RA and other CDDs.

Author Contributions

Conceptualization, L.D.R.; writing—original draft preparation, L.D.R., P.G., A.D.L.; writing—review and editing, P.G.; supervision, A.D.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Di Renzo, L.; Gualtieri, P.; Romano, L.; Marrone, G.; Noce, A.; Pujia, A.; Perrone, M.A.; Aiello, V.; Colica, C.; De Lorenzo, A. Role of personalized nutrition in chronic-degenerative diseases. Nutrients 2019, 11, 1707. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. World Health Organization. Noncommunicable Diseases Country Profiles 2018. Available online: https://www.who.int/nmh/publications/ncd-profiles-2018/en/ (accessed on 7 April 2021).
  3. Benziger, C.P.; Roth, G.A.; Moran, A.E. The global burden of disease study and the preventable burden of NCD. Glob. Heart 2016, 11, 393–397. [Google Scholar] [CrossRef] [PubMed]
  4. Noce, A.; Marrone, G.; Urciuoli, S.; Di Daniele, F.; Di Lauro, M.; Pietroboni Zaitseva, A.; Di Daniele, N.; Romani, A. Usefulness of extra virgin olive oil minor polar compounds in the management of chronic kidney disease patients. Nutrients 2021, 13, 581. [Google Scholar] [CrossRef] [PubMed]
  5. Domingues, W.J.R.; Ritti-Dias, R.M.; Cucato, G.G.; Wolosker, N.; Zerati, A.E.; Puech-Leão, P.; Coelho, D.B.; Nunhes, P.M.; Moliterno, A.A.; Avelar, A. Effect of creatine supplementation on functional capacity and muscle oxygen saturation in patients with symptomatic peripheral arterial disease: A pilot study of a randomized, double-blind placebo-controlled clinical trial. Nutrients 2021, 13, 149. [Google Scholar] [CrossRef] [PubMed]
  6. Jalal, S.M.; Alsultan, A.A.; Alotaibi, H.H.; Mary, E.; Alabdullatif, A.A.I. Effect of Phaseolus Vulgaris on urinary biochemical parameters among patients with kidney stones in Saudi Arabia. Nutrients 2020, 12, 3346. [Google Scholar] [CrossRef] [PubMed]
  7. Quattrini, S.; Pampaloni, B.; Gronchi, G.; Giusti, F.; Brandi, M.L. The mediterranean diet in osteoporosis prevention: An insight in a peri- and post-menopausal population. Nutrients 2021, 13, 531. [Google Scholar] [CrossRef] [PubMed]
  8. Di Renzo, L.; Cinelli, G.; Romano, L.; Zomparelli, S.; Lou De Santis, G.; Nocerino, P.; Bigioni, G.; Arsini, L.; Cenname, G.; Pujia, A.; et al. Potential effects of a modified mediterranean diet on body composition in lipoedema. Nutrients 2021, 13, 358. [Google Scholar] [CrossRef] [PubMed]
  9. Lombardo, M.; Perrone, M.A.; Guseva, E.; Aulisa, G.; Padua, E.; Bellia, C.; Della-Morte, D.; Iellamo, F.; Caprio, M.; Bellia, A. Losing weight after menopause with minimal aerobic training and mediterranean diet. Nutrients 2020, 12, 2471. [Google Scholar] [CrossRef] [PubMed]
  10. Muscogiuri, G.; Barrea, L.; Aprano, S.; Framondi, L.; Di Matteo, R.; Laudisio, D.; Pugliese, G.; Savastano, S.; Colao, A. On behalf of the Opera Prevention project. Sleep quality in obesity: Does adherence to the mediterranean diet matter? Nutrients 2020, 12, 1364. [Google Scholar] [CrossRef] [PubMed]
  11. Muscogiuri, G.; Barrea, L.; Aprano, S.; Framondi, L.; Di Matteo, R.; Laudisio, D.; Pugliese, G.; Savastano, S.; Colao, A. On behalf of the Opera Prevention project. Chronotype and adherence to the mediterranean diet in obesity: Results from the Opera Prevention project. Nutrients 2020, 12, 1354. [Google Scholar] [CrossRef] [PubMed]
  12. Merra, G.; Noce, A.; Marrone, G.; Cintoni, M.; Tarsitano, M.G.; Capacci, A.; De Lorenzo, A. Influence of mediterranean diet on human gut microbiota. Nutrients 2021, 13, 7. [Google Scholar] [CrossRef] [PubMed]
  13. Sánchez Macarro, M.; Martínez Rodríguez, J.P.; Bernal Morell, E.; Pérez-Piñero, S.; Victoria-Montesinos, D.; García-Muñoz, A.M.; Cánovas García, F.; Castillo Sánchez, J.; López-Román, F.J. Effect of a combination of citrus flavones and flavanones and olive polyphenols for the reduction of cardiovascular disease risk: An exploratory randomized, double-blind, placebo-controlled study in healthy subjects. Nutrients 2020, 12, 1475. [Google Scholar] [CrossRef] [PubMed]
  14. Ostrowska, J.; Janiszewska, J.; Szostak-Węgierek, D. Dietary acid load and cardiometabolic risk factors—a narrative review. Nutrients 2020, 12, 3419. [Google Scholar] [CrossRef] [PubMed]
  15. Fagerberg, P.; Klingelhoefer, L.; Bottai, M.; Langlet, B.; Kyritsis, K.; Rotter, E.; Reichmann, H.; Falkenburger, B.; Delopoulos, A.; Ioakimidis, I. Lower energy intake among advanced vs. early parkinson’s disease patients and healthy controls in a clinical lunch setting: A cross-sectional study. Nutrients 2020, 12, 2109. [Google Scholar] [CrossRef] [PubMed]
  16. Christodoulou, C.C.; Demetriou, C.A.; Zamba-Papanicolaou, E. Dietary intake, mediterranean diet adherence and caloric intake in Huntington’s disease: A review. Nutrients 2020, 12, 2946. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Di Renzo, L.; Gualtieri, P.; De Lorenzo, A. Diet, Nutrition and Chronic Degenerative Diseases. Nutrients 2021, 13, 1372. https://0-doi-org.brum.beds.ac.uk/10.3390/nu13041372

AMA Style

Di Renzo L, Gualtieri P, De Lorenzo A. Diet, Nutrition and Chronic Degenerative Diseases. Nutrients. 2021; 13(4):1372. https://0-doi-org.brum.beds.ac.uk/10.3390/nu13041372

Chicago/Turabian Style

Di Renzo, Laura, Paola Gualtieri, and Antonino De Lorenzo. 2021. "Diet, Nutrition and Chronic Degenerative Diseases" Nutrients 13, no. 4: 1372. https://0-doi-org.brum.beds.ac.uk/10.3390/nu13041372

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop